gms | German Medical Science

79. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

30.04. - 04.05.2008, Bonn

Management of oropharyngeal cancer in Cluj-Napoca ENT Department, Romania

Meeting Abstract

  • corresponding author Marcel Cosgarea - UNIVERSITÄT FÜR MEDIZIN " Iuliu Hatieganu", HNO-Klinik, CLUJ`- NAPOCA, RUMÄNIEN
  • Constantin Iencica - University of Medicine and Pharmacy "Iuliu Hatieganu" - ENT Department, Cluj-Napoca, Romania
  • Magdalena Chirila - Universitat fur Medizin, HNO-Klinik, Cluj-Napoca, Romania
  • Sever Pop - Universitat fur Medizin, HNO-Klinik, Cluj-Napoca, Romania
  • Violeta Necula - Universitat fur Medizin, HNO-Klinik, Cluj-Napoca, Romania
  • Alma Maniu - Universitat fur Medizin, HNO-Klinik, Cluj-Napoca, Romania

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. 79. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. Bonn, 30.04.-04.05.2008. Düsseldorf: German Medical Science GMS Publishing House; 2008. Doc08hnod479

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter: http://www.egms.de/de/meetings/hnod2008/08hnod479.shtml

Veröffentlicht: 22. April 2008

© 2008 Cosgarea et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielf&aauml;ltigt, verbreitet und &oauml;ffentlich zug&aauml;nglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Introduction: Despite the recent progresses in medicine, the oncological pathology is still a major challenge for many physicians.

Methods: A retrospective study was performed in the ENT Department from Cluj-Napoca, Romania on a period of 10 years (1995– 2005) when were treated over 3113 patients with head and neck cancer.

Results: The distribution of the cases was the following: a total of 3113 cancers, from which there were 684 patients with oral cavity cancer (22% ), 1371 patients had larynx cancer (44%), 467 Oropharynx cases (15%), 156 hypopharynx cases (5%), 156 major salivary gland cases (5%), 124 nasopharynx cases (4%), 143 nose and paranasal sinuses cases (4,6%) and 12 melanoma cases (0,4%). The modalities of treatment in ENT Clinic Cluj-Napoca were: surgery, radiation, combined surgery and radiation therapy, chemotherapy and chemoradiotherapy. Complications after surgical procedures were wound infection at 21% (98p), aspiration at 4% (18p), dysphagia at 43% (201p), nasal regurgitation at 15% (70p), hypernasal speech at 24% (112p), Eustachian tube dysfunction at 4% (18p), positive margins at 11% (51p), nonunion (mandibular complication) at 3% (15p), malunion (mandibular complication) at 1% (4p) and malocclusion (mandibular complication) at 4% (18p), where p=patient.

Conclusion: Surgery and radiotherapy are standard treatments. In advanced disease, chemotherapy may be useful as an adjunct to surgery and or radiation.